New NHS England cancer drug: Mirvetuximab soravtansine (Elahere) has been approved for resistant ovarian cancer, the first such approval in over two decades, with NHS access via a confidential commercial deal. Infant formula safety scrutiny: A report says infant formula contamination checks and public communication failed after cereulide toxin cases, with concerns that products may have been on sale months before the first official warning. Wellbeing fad warning: Medical experts are calling to ban Kambo “detox” treatments made from Amazonian frog secretions, after a UK death and wider international fatalities linked to the practice. Mental health and public safety: A review claims nearly all mentally ill killers had contact with services and/or police yet still “slipped through the cracks,” raising questions about discharge and medication adherence. Community care access: A new £15m Healthy Living Centre in Chatham is opening as a one-stop hub for GP and community services, aiming to tackle local health inequalities. NHS tech in surgery: St Mark’s used a UK-first AI system that colour-codes anatomy during live bowel surgery to help surgeons spot hidden structures. Workplace harm payouts: Norfolk figures show hundreds of healthcare worker claims and large settlements, including major payouts for assault and injury. Public health campaign: Wirral has launched “Think Contraception Before 21 Days” to highlight pregnancy risk soon after birth. Local health inspections: Greater Manchester CQC round-ups include an “inadequate” homecare service placed into special measures after safeguarding and care-record failures.